Tal Zvi Zaks - 19 May 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Medical Officer
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 19 May 2021
Net transactions value: -$649,050
Form type: 4
Filing time: 20 May 2021, 17:14:43 UTC
Previous filing: 13 May 2021
Next filing: 27 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$129,650	+5,000		$25.93	5,000	19 May 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	$778,700	-5,000	-100%	$155.74	0	19 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-5,000	-3.2%	$0.000000	151,120	19 May 2021	Common Stock	5,000	$25.93	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021.
F2	25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter.